Waystar Holding Corp. $WAY Shares Sold by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC decreased its holdings in Waystar Holding Corp. (NASDAQ:WAY) by 85.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,870 shares of the company’s stock after selling 90,670 shares during the period. Lisanti Capital Growth LLC’s holdings in Waystar were worth $487,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. ANTIPODES PARTNERS Ltd grew its stake in shares of Waystar by 120.1% in the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock worth $31,000 after acquiring an additional 449 shares in the last quarter. Danske Bank A S acquired a new position in shares of Waystar in the fourth quarter worth $52,000. EverSource Wealth Advisors LLC grew its stake in shares of Waystar by 3,219.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after acquiring an additional 1,352 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Waystar by 613.4% in the fourth quarter. GAMMA Investing LLC now owns 1,762 shares of the company’s stock worth $58,000 after acquiring an additional 1,515 shares in the last quarter. Finally, 1620 Investment Advisors Inc. acquired a new position in shares of Waystar in the fourth quarter worth $77,000.

Wall Street Analyst Weigh In

Several research firms have commented on WAY. Freedom Capital upgraded shares of Waystar from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, February 18th. Morgan Stanley began coverage on shares of Waystar in a research note on Monday, March 30th. They issued an “equal weight” rating and a $28.00 price target for the company. Needham & Company LLC restated a “buy” rating and issued a $33.00 price target on shares of Waystar in a research note on Thursday, April 30th. Mizuho set a $42.00 price target on shares of Waystar in a research note on Wednesday, February 4th. Finally, Bank of America dropped their price target on shares of Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a research note on Friday, April 10th. Four research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Waystar presently has a consensus rating of “Buy” and an average price target of $35.62.

Waystar Price Performance

Waystar stock opened at $19.57 on Monday. The stock has a market cap of $3.75 billion, a P/E ratio of 29.21, a price-to-earnings-growth ratio of 0.77 and a beta of 0.21. The company has a fifty day simple moving average of $22.87 and a 200-day simple moving average of $27.85. Waystar Holding Corp. has a 12-month low of $17.89 and a 12-month high of $41.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.37.

Waystar (NASDAQ:WAY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.03. The business had revenue of $313.87 million during the quarter, compared to analysts’ expectations of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Equities analysts expect that Waystar Holding Corp. will post 1.45 EPS for the current fiscal year.

Waystar Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.